CAPITOL COUNSEL LLC

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Jan 18, 2026

Lobbying activity 2

Medicare/Medicaid

Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.

Taxation/Internal Revenue Code

Issues related to international tax.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.